Filter
538
Text search:
experimental
drug
Featured
Recommendations
43
New Publications
96
Language
Document type
No document type
312
Studies & Reports
93
Guidelines
71
Manuals
28
Strategic & Response Plan
11
Training Material
7
Fact sheets
7
Situation Updates
5
Resource Platforms
4
Countries / Regions
India
26
Global
18
Western and Central Europe
16
Latin America and the Carribbean
12
Kenya
11
Ethiopia
9
Rwanda
9
South Africa
9
Sierra Leone
7
Uganda
6
Ukraine
6
Liberia
5
Nigeria
5
Germany
5
Tanzania
5
Bangladesh
5
Brazil
5
Eastern Europe
5
Ghana
4
Zimbabwe
4
Nepal
4
South Sudan
4
Africa
4
Russia
4
Congo, Democratic Republic of
3
USA
3
Philippines
3
Malawi
3
Argentina
3
Colombia
3
Myanmar / Burma
3
West and Central Africa
3
Middle East and North Africa
3
South–East Asia Region
3
Burkina Faso
2
Senegal
2
Cameroon
2
Haiti
2
Zambia
2
Indonesia
2
Eswatini/ Swaziland
2
Lesotho
2
Eastern Europe and Central Asia
2
Venezuela
2
Tajikistan
2
Guinea
1
Côte d’Ivoire / Ivory Coast
1
Syria
1
Thailand
1
China
1
Mozambique
1
Namibia
1
Peru
1
Botswana
1
Yemen
1
East and Southern Africa
1
Paraguay
1
Asia
1
Canada
1
Uzbekistan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
134
Clinical Guidelines
60
Public Health
36
Women & Child Health
12
Key Resources
11
Capacity Building
6
Pharmacy & Technologies
6
Toolboxes
Mental Health
97
TB
43
HIV
38
COVID-19
38
Ebola
32
NTDs
30
Rapid Response
27
Pharmacy
21
AMR
19
Caregiver
15
Planetary Health
12
NCDs
11
Disability
10
Global Health Education
6
Zika
4
Conflict
3
Refugee
3
Health Financing Toolbox
3
Natural Hazards
2
Specific Hazards
2
Cholera
1
Includes a Special Report on the Financial and Personal Benefits of Early Diagnosis
2018 Alzheimer’s Disease Facts and Figures is a statistical resource for U.S. data related to Alzheimer’s disease,
the most common cause of dementia. Background and context for interpretating the data are con
...
Q4: Can convulsive epilepsy be diagnosed at first level care by a non-specialist health care provider in low and middle income country settings?
Ann Indian Acad Neurol. 2015 Sep; 18(Suppl 1): S2–S5.
doi: 10.4103/0972-2327.164812
PMCID: PMC4604693
PMID: 26538844
Int J Health Geogr. 2002; 1: 5.
Published online 2002 Dec 20. doi: 10.1186/1476-072X-1-5
PMCID: PMC149400
PMID: 12537588
WHO Western Pacific Regional Strategy to Reduce Alcohol-Related Harm
Rapid review and case studies from Member States
Perspectivas sobre las drogas
Introducción
Capítulo A.6
Edición: Matías Irarrázaval & Andres Martin
Traductores: Fernanda Prieto-Tagle & Jaume Morey
Introducción
Capítulo A.14
Edición: Matías Irarrázaval & Andres Martin
Revisión: Fernanda Prieto-Tagle & Neus Elias
Trastornos externalizantes
Capítulo D.3
Edición: Matías Irarrázaval & Andres Martin
Traducción: Fernanda Prieto Tagle, Sofía Hacohen Domené
Trastornos de ansiedad
Capítulo F.1
Edición en español
Editor: Matías Irarrázaval
Traducción: Matías Irarrázaval y María Tatiana Estefan
Trastornos de ansiedad
Capítulo F.2
Versión en español:
Editor: Cesar Soutullo
Traductores: Andrea Candelas-Muñoz, Cecilia Hernández-González, Ana Mena
Otros trastornos
Capítulo H.5
Edición: Matías Irarrázaval & Andres Martin
Traducción: María Fernanda Prieto
Divers
Chapitre J.1
Edition en français
Traduction : Laure Woestelandt, Jordan Sibeoni Sous la direction de : Marie-Rose Moro Avec le soutien de la SFPEADA
Troubles anxieux
Chapitre F.1
Edition en français Traduction : Jean-Philippe Raynaud Avec le soutien de la SFPEADA
Autres troubles
Chapitre H.5
Edition en français Traduction : Bojan Mirkovic Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
Patel V, Chisholm D, Dua T, et al., editors.
Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2016 Mar 14.
Introduction
Chapitre A.6
Edition en français Traduction : Cristina Constantin Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA
Le trouble anxiété de séparation (TAS) représente environ la moitié de l’ensemble des troubles anxieux
(Cartwright-Harton et al, 2006). La plupart des troubles anxieux pédiatriques
présentent les mêmes critères diagnostics que chez l’adulte à l’exception du TAS,
actuellement class
...